Q5A(R2) (Step 4, 1 November 2023)
Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
ICHICH guidelineOtherBiologicsHigh confidenceLast verified October 4, 2026
Describes how to evaluate the viral safety of biotechnology products made from human or animal cell lines, including viral clearance and testing, and what data go into a marketing application.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
| Market | Status | Edition accepted | National code | Details |
|---|
| United States | Adopted | - | Vol. 89, p. 1925 (89 FR 1925) | Effective January 11, 2024 |
| European Union | Adopted | - | EMA/CHMP/ICH/804363/2022 | Effective June 14, 2024 |
|
Related standards: Q5B, Q5D, Q5E, Q8(R2), Q11, Q12, Q13, ISO/IEC 17050-1, AS/NZS 3551, UN Manual of Tests and Criteria, section 38.3. See all standards.
Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.